Die Bedeutung der kognitiven Dysfunktion in der onkologischen Rehabilitation
GMS Onkologische Rehabilitation und Sozialmedizin; 10:Doc01 · 19.09.2018 · 1-1
DOI: 10.3205/ors000035 ↗Kurz gefasst
Fachartikel in der Zeitschrift GMS Onkologische Rehabilitation und Sozialmedizin; 10:Doc01, erschienen am 19.09.2018. Verfasst von Rick und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cognitive dysfunction (CD) in the form of concentration and memory impairment is detected in up to 75% of cancer patients. In particular, women after breast cancer are affected by CD in about 30% of the cases. After chemotherapy, a deterioration of cognitive function is often observed and the function even remains reduced in the long term in 15–45% of the patients. In general, CD is assumed to be related to the respective anti-tumor treatment. Between 1995 and 2012, 53 studies were published that suggest an effect of chemotherapy on cognitive dysfunction. However, CD seems to be a complex problem in cancer patients and cannot be simply reduced to the chemotherapy performed. It could be demonstrated that factors such as depression, anxiety, and fatigue play a role as well. Moreover, a subjectively perceived poor quality of life also appears to have a negative impact on cognitive function. In particular, the effects of a post-traumatic stress situation at the diagnosis of cancer on a person's mental health are individually different and can also cause impairment of the cognitive performance.
Schlagwörter
Zitieren
APA
Rick, & Oliver (2018). Die Bedeutung der kognitiven Dysfunktion in der onkologischen Rehabilitation. GMS Onkologische Rehabilitation und Sozialmedizin; 10:Doc01, 1-1. https://doi.org/10.3205/ors000035
Vancouver
Rick, Oliver. Die Bedeutung der kognitiven Dysfunktion in der onkologischen Rehabilitation. GMS Onkologische Rehabilitation und Sozialmedizin; 10:Doc01. 2018:1-1. doi:10.3205/ors000035
BibTeX
@article{Rick2018,
author = {Rick and Oliver},
title = {Die Bedeutung der kognitiven Dysfunktion in der onkologischen Rehabilitation},
journal = {GMS Onkologische Rehabilitation und Sozialmedizin; 10:Doc01},
year = {2018},
pages = {1--1},
doi = {10.3205/ors000035}
}
EUVIMED